514
Views
4
CrossRef citations to date
0
Altmetric
Review

New and emerging cardiovascular and antihypertensive drugs

&
Pages 1315-1327 | Received 15 Jun 2020, Accepted 11 Aug 2020, Published online: 29 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Steven G. Chrysant. (2021) A novel approach for the treatment of hypertension with the soluble guanylate cyclase stimulating drug. Expert Opinion on Drug Safety 20:6, pages 635-640.
Read now

Articles from other publishers (3)

Windingoudi Rimwagna Christian Ouedraogo, Lazare Belemnaba, Mathieu Nitiema, Boukaré KaboreNoufou Ouedraogo, Moumouni Koala, Rasmané Semde & Sylvin Ouedraogo. (2023) Antioxidant and Vasorelaxant Properties of Phaseolus vulgaris Linn (Fabaceae) Immature Pods Extract on the Thoracic Aorta of NMRI Mice. Biomedical and Pharmacology Journal 16:1, pages 533-548.
Crossref
Annalaura Brai, Claudia Immacolata Trivisani, Chiara Vagaggini, Roberto Stella, Roberto Angeletti, Giulia Iovenitti, Valeria Francardi & Elena Dreassi. (2022) Proteins from Tenebrio molitor: An interesting functional ingredient and a source of ACE inhibitory peptides. Food Chemistry 393, pages 133409.
Crossref
Katharina Brandl, Stephen Schneid & Nora Laiken. (2022) A small‐group activity to enhance learning of cardiovascular drugs for health science students. Pharmacology Research & Perspectives 10:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.